Ernest CS[au] - Search Results

Year	Number of Results
2001	1
2002	1
2004	2
2005	2
2006	5
2007	4
2008	5
2009	7
2010	3
2011	2
2012	1
2013	1
2022	1

1

Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.

Small DS, Farid NA, Li YG, Ernest CS 2nd, Payne CD, Salazar DE, Winters KJ. Small DS, et al. Among authors: ernest cs 2nd. Curr Med Res Opin. 2008 Aug;24(8):2251-7. doi: 10.1185/03007990802205985. Curr Med Res Opin. 2008. PMID: 18786302 Clinical Trial.

2

Cognitive function in candidates for coronary artery bypass graft surgery.

Ernest CS, Murphy BM, Worcester MU, Higgins RO, Elliott PC, Goble AJ, Le Grande MR, Genardini N, Tatoulis J. Ernest CS, et al. Ann Thorac Surg. 2006 Sep;82(3):812-8. doi: 10.1016/j.athoracsur.2006.04.005. Ann Thorac Surg. 2006. PMID: 16928490

3

Mechanism-based inactivation of CYP3A by HIV protease inhibitors.

Ernest CS 2nd, Hall SD, Jones DR. Ernest CS 2nd, et al. J Pharmacol Exp Ther. 2005 Feb;312(2):583-91. doi: 10.1124/jpet.104.075416. Epub 2004 Nov 2. J Pharmacol Exp Ther. 2005. PMID: 15523003

4

Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects.

Farid NA, Small DS, Payne CD, Jakubowski JA, Brandt JT, Li YG, Ernest CS, Salazar DE, Konkoy CS, Winters KJ. Farid NA, et al. Among authors: ernest cs. Pharmacotherapy. 2008 Dec;28(12):1483-94. doi: 10.1592/phco.28.12.1483. Pharmacotherapy. 2008. PMID: 19025429 Clinical Trial.

5

Pharmacokinetics and pharmacodynamics of prasugrel in subjects with moderate liver disease.

Small DS, Farid NA, Li YG, Ernest CS 2nd, Winters KJ, Salazar DE, Payne CD. Small DS, et al. Among authors: ernest cs 2nd. J Clin Pharm Ther. 2009 Oct;34(5):575-83. doi: 10.1111/j.1365-2710.2009.01067.x. J Clin Pharm Ther. 2009. PMID: 19744013

6

PK/PD modeling links accelerated resolution of COVID-19-related clinical symptoms to SARS-CoV-2 viral load reduction in patients following treatment with Bamlanivimab alone or Bamlanivimab and Etesevimab together.

Ernest CS 2nd, Chien JY, Patel DR, Chigutsa E. Ernest CS 2nd, et al. CPT Pharmacometrics Syst Pharmacol. 2022 Jun;11(6):721-730. doi: 10.1002/psp4.12784. Epub 2022 Apr 5. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35289125 Free PMC article. Clinical Trial.

7

Predictors of cognitive function in candidates for coronary artery bypass graft surgery.

Ernest CS, Elliott PC, Murphy BM, Le Grande MR, Goble AJ, Higgins RO, Worcester MU, Tatoulis J. Ernest CS, et al. J Int Neuropsychol Soc. 2007 Mar;13(2):257-66. doi: 10.1017/S1355617707070282. J Int Neuropsychol Soc. 2007. PMID: 17286883

8

Methodological comparison of in vitro binding parameter estimation: sequential vs. simultaneous non-linear regression.

Ernest CS 2nd, Hooker AC, Karlsson MO. Ernest CS 2nd, et al. Pharm Res. 2010 May;27(5):866-77. doi: 10.1007/s11095-010-0082-1. Epub 2010 Mar 11. Pharm Res. 2010. PMID: 20221897

9

Relationship between exposure to prasugrel active metabolite and clinical outcomes in the TRITON-TIMI 38 substudy.

Riesmeyer JS, Salazar DE, Weerakkody GJ, Ni L, Wrishko RE, Ernest CS 2nd, Luo J, Li YG, Small DS, Rohatagi S, Macias WL. Riesmeyer JS, et al. Among authors: ernest cs 2nd. J Clin Pharmacol. 2012 Jun;52(6):789-97. doi: 10.1177/0091270011406280. Epub 2011 May 31. J Clin Pharmacol. 2012. PMID: 21628601 Clinical Trial.

10

Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently.

Farid NA, Payne CD, Small DS, Winters KJ, Ernest CS 2nd, Brandt JT, Darstein C, Jakubowski JA, Salazar DE. Farid NA, et al. Among authors: ernest cs 2nd. Clin Pharmacol Ther. 2007 May;81(5):735-41. doi: 10.1038/sj.clpt.6100139. Epub 2007 Mar 14. Clin Pharmacol Ther. 2007. PMID: 17361128 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results